Literature DB >> 10458403

Differential expression of C-CAM cell adhesion molecule in prostate carcinogenesis in a transgenic mouse model.

Y S Pu1, W Luo, H H Lu, N M Greenberg, S H Lin, J R Gingrich.   

Abstract

PURPOSE: The transgenic adenocarcinoma of mouse prostate (TRAMP) model, in which various grades of prostate intraepithelial neoplasia (PIN) and prostate cancer with metastases can be reproducibly generated, is a paradigm for prostate disease progression. We have previously shown that C-CAM, an adhesion molecule, can suppress the growth of prostate cancer. In this report, we describe immunohistochemical characterization of differential expression of C-CAM at various stages of prostate tumorigenesis in the TRAMP model.
MATERIALS AND METHODS: We sampled prostate specimens and periaortic lymph nodes from TRAMP mice. Indirect immunohistochemical staining with a polyclonal anti-C-CAM antibody was performed on the formalin-fixed, paraffin-embedded specimens. After castration at 12 weeks of age, the TRAMP mice developed androgen-independent prostate cancer (AIPC) and lymph node metastasis at 18 to 24 weeks of age. Samples from these castrated mice were also analyzed.
RESULTS: C-CAM protein was expressed in the normal prostate epithelia of non-transgenic and TRAMP mice as well as in low-grade PINs in TRAMP mice. Expression was uniform on the luminal surfaces of these epithelia. C-CAM expression was noticeably reduced and the staining pattern heterogeneous in some high-grade PINs. C-CAM staining was generally absent in prostate cancer and metastatic lymph nodes. Androgen independent prostate cancer and its metastatic tumors generated in castrated TRAMP mice were also C-CAM negative.
CONCLUSIONS: C-CAM expression correlates with the differentiation states of prostate epithelia and is down regulated early in prostate tumorigenesis in the TRAMP model.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10458403     DOI: 10.1097/00005392-199909010-00085

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Differences in tissue-specific and embryonic expression of mouse Ceacam1 and Ceacam2 genes.

Authors:  E Han; D Phan; P Lo; M N Poy; R Behringer; S M Najjar; S H Lin
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

Review 2.  Immunopathological prognostic and predictive factors in prostate cancer.

Authors:  E Sivridis; S Touloupidis; A Giatromanolaki
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

3.  CEACAM1-4S, a cell-cell adhesion molecule, mediates apoptosis and reverts mammary carcinoma cells to a normal morphogenic phenotype in a 3D culture.

Authors:  Julia Kirshner; Charng-Jui Chen; Pingfang Liu; Jie Huang; John E Shively
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-09       Impact factor: 11.205

4.  Altered splicing of CEACAM1 in breast cancer: identification of regulatory sequences that control splicing of CEACAM1 into long or short cytoplasmic domain isoforms.

Authors:  Shikha Gaur; John E Shively; Yun Yen; Rajesh K Gaur
Journal:  Mol Cancer       Date:  2008-05-28       Impact factor: 27.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.